NM_004655.4:c.1573C>T
Variant names: 
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2
The NM_004655.4(AXIN2):c.1573C>T(p.Pro525Ser) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P525L) has been classified as Uncertain significance.
Frequency
 Genomes: not found (cov: 32) 
Consequence
 AXIN2
NM_004655.4 missense
NM_004655.4 missense
Scores
 2
 6
 10
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  5.15  
Publications
0 publications found 
Genes affected
 AXIN2  (HGNC:904):  (axin 2) The Axin-related protein, Axin2, presumably plays an important role in the regulation of the stability of beta-catenin in the Wnt signaling pathway, like its rodent homologs, mouse conductin/rat axil. In mouse, conductin organizes a multiprotein complex of APC (adenomatous polyposis of the colon), beta-catenin, glycogen synthase kinase 3-beta, and conductin, which leads to the degradation of beta-catenin. Apparently, the deregulation of beta-catenin is an important event in the genesis of a number of malignancies. The AXIN2 gene has been mapped to 17q23-q24, a region that shows frequent loss of heterozygosity in breast cancer, neuroblastoma, and other tumors. Mutations in this gene have been associated with colorectal cancer with defective mismatch repair. [provided by RefSeq, Jul 2008] 
AXIN2 Gene-Disease associations (from GenCC):
- oligodontia-cancer predisposition syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
- tooth agenesisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- craniosynostosisInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage; 
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| AXIN2 | ENST00000307078.10 | c.1573C>T | p.Pro525Ser | missense_variant | Exon 6 of 11 | 1 | NM_004655.4 | ENSP00000302625.5 | ||
| AXIN2 | ENST00000375702.5 | c.1573C>T | p.Pro525Ser | missense_variant | Exon 5 of 9 | 1 | ENSP00000364854.5 | |||
| AXIN2 | ENST00000618960.4 | c.1573C>T | p.Pro525Ser | missense_variant | Exon 6 of 10 | 5 | ENSP00000478916.1 | 
Frequencies
GnomAD3 genomes  
GnomAD3 genomes 
Cov.: 
32
GnomAD4 exome Cov.: 35 
GnomAD4 exome 
Cov.: 
35
GnomAD4 genome  
GnomAD4 genome 
Cov.: 
32
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 AlphaMissense 
 Benign 
 BayesDel_addAF 
 Benign 
T 
 BayesDel_noAF 
 Benign 
 DANN 
 Uncertain 
 DEOGEN2 
 Benign 
.;T;T 
 Eigen 
 Uncertain 
 Eigen_PC 
 Uncertain 
 FATHMM_MKL 
 Uncertain 
D 
 LIST_S2 
 Pathogenic 
.;D;. 
 M_CAP 
 Pathogenic 
D 
 MetaRNN 
 Uncertain 
D;D;D 
 MetaSVM 
 Benign 
T 
 PhyloP100 
 PrimateAI 
 Uncertain 
T 
 PROVEAN 
 Benign 
N;.;N 
 REVEL 
 Benign 
 Sift 
 Benign 
T;.;T 
 Sift4G 
 Benign 
T;T;T 
 Polyphen 
 0.99 
.;D;D 
 Vest4 
 MutPred 
Gain of glycosylation at P525 (P = 0.0582);Gain of glycosylation at P525 (P = 0.0582);Gain of glycosylation at P525 (P = 0.0582);
 MVP 
 MPC 
 ClinPred 
D 
 GERP RS 
 RBP_binding_hub_radar 
 RBP_regulation_power_radar 
 gMVP 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.